<DOC>
	<DOCNO>NCT01901692</DOCNO>
	<brief_summary>To evaluate compare efficacy safety trans-arterial chemoembolization plus external beam radiation therapy sorafenib patient hepatocellular carcinoma invade major intrahepatic vessel</brief_summary>
	<brief_title>Transarterial Chemoembolization Plus Radiotherapy Sorafenib Hepatocellular Carcinoma With Major Vascular Invasion</brief_title>
	<detailed_description>Current practice guideline recommend sorafenib patient hepatocellular carcinoma invade major intrahepatic vessel . However , recent data suggest combination transarterial chemoembolization external beam radiotherapy would effective sorafenib .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Sorafenib</mesh_term>
	<mesh_term>Niacinamide</mesh_term>
	<criteria>Age &gt; 19 year ChildPugh class A liver function Performance status : Eastern Cooperative Oncology Group ( ECOG ) score 0 1 Hepatocellular carcinoma ( HCC ) confirm dynamic CT MRI , biopsy HCC invasion first second branch portal vein hepatic vein inferior vena cava Reserved unilateral portal blood flow least partial HCC size large 1 cm less 50 % total liver volume No extrahepatic metastasis Adequate hematopoietic function Hemoglobin ≥ 8.5 g/dL Absolute neutrophil count ≥ 750/mm3 Platelet count ≥ 30,000/mm3 Creatinine &lt; 1.5mg/dL No plan pregnancy breast feeding . Active contraception . Willing give inform consent Prior history exposure transarterial chemoembolization , external beam radiation liver , sorafenib Complete obstruction hepatic outflow Confirmed extrahepatic metastasis HCC HCC occupy 50 % liver volume Uncontrolled ascites hepatic encephalopathy Prior liver transplantation Positive human immunodeficiency virus ( HIV ) Active gastric duodenal ulcer Other uncontrolled comorbidities malignancy Inability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>